Levemir (Novo Nordisk)
Welcome to the PulseAid listing for the Levemir drug offered from Novo Nordisk. This Insulin [Chemical/Ingredient],Insulin Analog [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Novo Nordisk |
NON-PROPRIETARY NAME: | insulin detemir |
SUBSTANCE NAME: | INSULIN DETEMIR |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Insulin [Chemical/Ingredient],Insulin Analog [EPC] |
ROUTE: | SUBCUTANEOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2006-03-27 |
END MARKETING DATE: | 0000-00-00 |
Levemir HUMAN PRESCRIPTION DRUG Details:
Item Description | Levemir from Novo Nordisk |
LABELER NAME: | Novo Nordisk |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100([iU]/mL) |
START MARKETING DATE: | 2006-03-27 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0169-3687_a0ad4ce8-1e36-4b1f-bcd2-d73a8680d764 |
PRODUCT NDC: | 0169-3687 |
APPLICATION NUMBER: | NDA021536 |
Other INSULIN DETEMIR Pharmaceutical Manufacturers / Labelers: